Stock Track | Mind Medicine Shares Soar 6% on Upbeat Earnings and Bullish Analyst Actions

Stock Track11-08

Shares of Mind Medicine (MindMed) Inc. (MNMD) surged 6.27% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and positive analyst actions raising price targets and ratings.

MindMed reported a quarterly adjusted loss of $0.27 per share for the quarter ended September 30, narrower than the $0.28 per share loss expected by analysts. The company's reported EPS was a loss of $0.27, and it posted a quarterly net loss of $13.68 million, which was an improvement over the same period last year.

Following the earnings release, analysts at Canaccord raised their price target on MindMed to $16 from $14, maintaining a Buy rating on the shares. Additionally, RBC also boosted its price target on the stock to $21 from $20. The bullish analyst actions and MindMed's upbeat quarterly performance appear to have fueled the stock's sharp rise on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147863866?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-08 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147863866","market":"hk","top_or_hot":-1,"title":"Stock Track | Mind Medicine Shares Soar 6% on Upbeat Earnings and Bullish Analyst Actions","media":"Stock Track","content":"<p>Shares of Mind Medicine (MindMed) Inc. (MNMD) surged 6.27% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and positive analyst actions raising price targets and ratings.</p>\n\n<p>MindMed reported a quarterly adjusted loss of $0.27 per share for the quarter ended September 30, narrower than the $0.28 per share loss expected by analysts. The company's reported EPS was a loss of $0.27, and it posted a quarterly net loss of $13.68 million, which was an improvement over the same period last year.</p>\n\n<p>Following the earnings release, analysts at Canaccord raised their price target on MindMed to $16 from $14, maintaining a Buy rating on the shares. Additionally, RBC also boosted its price target on the stock to $21 from $20. The bullish analyst actions and MindMed's upbeat quarterly performance appear to have fueled the stock's sharp rise on Thursday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Mind Medicine Shares Soar 6% on Upbeat Earnings and Bullish Analyst Actions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Mind Medicine Shares Soar 6% on Upbeat Earnings and Bullish Analyst Actions\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-08 22:37 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Mind Medicine (MindMed) Inc. (MNMD) surged 6.27% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and positive analyst actions raising price targets ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNMD","symbol_name":"Mind Medicine (MindMed) Inc.","start_time":0,"source_url":"","article_id":"1147863866","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147863866","pubTimestamp":1731076652,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Mind Medicine  Inc.  surged 6.27% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and positive analyst actions raising price targets and ratings.MindMed reported a quarterly adjusted loss of $0.27 per share for the quarter ended September 30, narrower than the $0.28 per share loss expected by analysts. The company's reported EPS was a loss of $0.27, and it posted a quarterly net loss of $13.68 million, which was an improvement over the same per","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc."},"translate_title":"股票追踪Mind Medicine股价因乐观的盈利和看涨的分析师行动而飙升6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNMD":1},"content_text":"Shares of Mind Medicine (MindMed) Inc. (MNMD) surged 6.27% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and positive analyst actions raising price targets and ratings.\nMindMed reported a quarterly adjusted loss of $0.27 per share for the quarter ended September 30, narrower than the $0.28 per share loss expected by analysts. The company's reported EPS was a loss of $0.27, and it posted a quarterly net loss of $13.68 million, which was an improvement over the same period last year.\nFollowing the earnings release, analysts at Canaccord raised their price target on MindMed to $16 from $14, maintaining a Buy rating on the shares. Additionally, RBC also boosted its price target on the stock to $21 from $20. The bullish analyst actions and MindMed's upbeat quarterly performance appear to have fueled the stock's sharp rise on Thursday.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147863866"}